- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: India
India Pharma Fund Ltd
+ Add to WatchlistINPHRMA:MP
24.95 USD 0.24 0.95%As of 00:59:30 ET on 05/21/2013.
Snapshot for India Pharma Fund Ltd (INPHRMA)
| Year To Date: | +4.31% | 3-Month: | +8.76% | 3-Year: | +7.34% | 52-Week Range: | 18.09 - 25.89 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.55% | 1-Year: | +27.49% | 5-Year: | +10.59% | Beta vs SEMDEX: | 0.46 |
Fund Profile & Information for INPHRMA
India Pharma Fund Limited is an open-end fund incorpoated in Mauritius. The objective is to achieve capital appreciation. The Fund invests in a portfolio of equity and equity-linked securities, principally of listed Indian pharmaceutical companies. The Fund also invests in related sectors such as biotechnology and healthcare.
| Inception Date: | 03-22-2005 | Telephone: | +44 1481 726141 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.uti-intl.co.uk | ||
Fundamentals for INPHRMA
| NAV | (on 2013-05-21) 24.95 |
|---|---|
| Assets (M) | (on 2011-10-31) 12.98 |
| Fund Leveraged | N |
| Minimum Investment | 100,000.00 |
| Minimum Subsequent Investment | 10,000.00 |
Dividends for INPHRMA
No dividends reported
Fees & Expenses for INPHRMA
| Front Load | 5.00 |
|---|---|
| Back Load | 0.50 |
| Current Mgmt Fee | 1.00 |
| Redemption Fee | 0.50 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for INPHRMA
Holding Data Unavailable.
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page